Personalized breast cancer prevention now available for women 30+ in the UK
Reports and Proceedings
Updates every hour. Last Updated: 13-Jul-2025 15:11 ET (13-Jul-2025 19:11 GMT/UTC)
A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast cancer and take early action years before NHS screening begins.
This study introduces a deep-learning system for rapid, automated detection and classification of tiny calcium deposits (microcalcifications) in mammograms to aid early breast cancer diagnosis. Leveraging a multi-center dataset of 4,810 biopsy-confirmed mammograms, our pipeline uses a Faster RCNN model with a feature-pyramid backbone to detect and classify microcalcifications—the pipeline requires no hand-tuned rules and provides both the overall cancer risk and highlighted lesion regions in seconds per image. On unseen test data, it achieved overall classification accuracy of 72% for discriminating between benign and malignant breasts and 78% sensitivity of malignant breast cancer prediction, marking a significant step toward AI-assisted, cost-effective breast-cancer screening that can run on standard radiology workstations.
A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration with biotech company, KYAN Technologies, has demonstrated that a precision medicine approach improves treatment selection for patients with soft tissue sarcomas (STS) in a clinical setting. Published in npj Precision Oncology in March 2025, the study’s findings support using data-driven and phenotypic screening approaches to treat STS.